Pricing Log in Create free account

Clearmind Medicine Inc. (CMND) vs Cadrenal Therapeutics, Inc. (CVKD)

Clearmind Medicine Inc. and Cadrenal Therapeutics, Inc. are both Biotechnology companies. Clearmind Medicine Inc. and Cadrenal Therapeutics, Inc. are of similar size ($3.5M and $3.3M). Across the 10 metrics below, Clearmind Medicine Inc. leads on 7 and Cadrenal Therapeutics, Inc. on 3.

Valuation

Metric CMND CVKD Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.76 0.78 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.49 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (1,476.45%) (449.54%) (33.15%)
Free cash flow yield (71.38%) (320.05%) (25.50%)

Profitability

Metric CMND CVKD Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (106.98%) (275.16%) (56.36%)
Return on assets (71.81%) (199.59%) (48.04%)
Return on invested capital 0.00% (427.54%) 0.00%

Growth

Metric CMND CVKD Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 55.10% 23.94% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CMND CVKD Biotechnology median
Debt to equity 0.13 0.00 0.00
Current ratio 4.31 3.73 4.72
Net debt to EBITDA 0.68 0.30 0.96

Dividend

Metric CMND CVKD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CMND CVKD Biotechnology median
Market cap 3.26m 3.46m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack